探索免疫细胞在质瘤中的作用:因果关联和临床影响
Yimin Pan1,2,3, Xiaoshun Sun1, Fushu Luo1
1Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, China.
International journal of medical sciences
|July 14, 2025
概括
这项研究表明,特定的免疫细胞特征因果关系地影响质瘤风险,并与质瘤特征和药物敏感性有关,这表明潜在的基于免疫细胞的生物标志物.
科学领域:
- 神经瘤学神经瘤学
- 免疫学 免疫学 免疫学
- 遗传学 遗传学是一种遗传学.
背景情况:
- 质瘤是中枢神经系统的侵略性瘤,结果不好.
- 免疫细胞显著影响固体瘤的进展,包括质瘤.
- 了解免疫细胞的作用对于质瘤研究至关重要.
研究的目的:
- 研究免疫细胞特征与质瘤风险之间的因果关系.
- 探索免疫细胞丰富度和质瘤临床特征之间的关联.
- 为了确定免疫细胞相关的生物标志物用于质瘤治疗.
主要方法:
- 使用GWAS数据对731个免疫细胞特征和质瘤进行双样本孟德尔随机化 (MR) 分析.
- 逆方差加权 (IVW) 方法,并进行强度的补充分析.
- 质瘤队列 (CSUXY和TCGA) 的RNA-Seq分析,以评估免疫细胞透和临床相关性.
主要成果:
- 确定了16种免疫细胞特征,对质瘤风险有潜在的因果关系.
- 在IDH野生型和1p19q非体质瘤中观察到更高的免疫细胞透率.
- 发现免疫细胞丰度,质瘤等级,亚型,预后和药物敏感性之间存在显著的关联.
结论:
- 特定的免疫细胞特征对质瘤的发展有因果影响.
- 免疫细胞透模式与关键质瘤临床特征相关.
- 免疫细胞的丰富性与药物敏感性有关,支持生物标志物的发展.
相关概念视频
The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Cytotoxic T Cells-mediated Immune Response
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.


